<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-05-16-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0720-AB85</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>202504</PUBLICATION_ID>
            <PUBLICATION_TITLE>Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0720</CODE>
            <NAME>Office of Assistant Secretary for Health Affairs</NAME>
            <ACRONYM>DODOASHA</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>0700</CODE>
            <NAME>Department of Defense</NAME>
            <ACRONYM>DOD</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>TRICARE Removal of Temporary Regulation Change and Freestanding End-Stage Renal Disease (ESRD) Facilities as TRICARE-Authorized Institutional Providers and Reimbursement Methods for ESRD facilities</RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>This rule finalizes an interim final rule that amended 32 CFR part 199 by: (1) adding freestanding End Stage Renal Disease (ESRD) facilities as a category of TRICARE-authorized institutional provider and modifying the reimbursement for such facilities; and (2) temporarily adopting Medicare&rsquo;s New COVID-19 Treatments Add-on Payment (NCTAP).&nbsp; The ESRD provisions are permanent, and the temporary NCTAP provisions expire at the end of the fiscal year in which the Secretary of Health and Human Services&rsquo; declared coronavirus disease 2019 (COVID-19) public health emergency ends.</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Other Significant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Final Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <EO_13771_DESIGNATION>Fully or Partially Exempt</EO_13771_DESIGNATION>
        <CFR_LIST>
            <CFR>32 CFR 199</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>5 U.S.C. 301</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>10 U.S.C. ch. 55</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>Yes</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>Interim Final Rule</TTBL_ACTION>
                <TTBL_DATE>01/12/2023</TTBL_DATE>
                <FR_CITATION>88 FR 1992</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Interim Final Rule Effective</TTBL_ACTION>
                <TTBL_DATE>01/12/2023</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Interim Final Rule Comment Period End</TTBL_ACTION>
                <TTBL_DATE>03/13/2023</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Final Action</TTBL_ACTION>
                <TTBL_DATE>12/00/2025</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Sharon</FIRST_NAME>
                <LAST_NAME>Seelmeyer</LAST_NAME>
                <PREFIX>Ms.</PREFIX>
                <TITLE>Medical Benefits and Reimbursement Section</TITLE>
                <AGENCY>
                    <CODE>0720</CODE>
                    <NAME>Office of Assistant Secretary for Health Affairs</NAME>
                    <ACRONYM>DODOASHA</ACRONYM>
                </AGENCY>
                <PHONE>303 676-3690</PHONE>
                <EMAIL>sharon.l.seelmeyer.civ@health.mil</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>16401 E Centretech Pkwy,</STREET_ADDRESS>
                    <CITY>Aurora</CITY>
                    <STATE>CO</STATE>
                    <ZIP>80011-9066</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
